Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identifying the time of HIV infection

20.01.2011
Genetic variety of the virus causing AIDS as a time indicator

Researchers of the Swiss HIV Cohort Study have identified a simple method to establish when a patient contracted the virus causing . The time of infection can be of importance for the treatment of the illness and it contributes to the understanding of the course of the epidemic.

Medical doctors rarely know when a patient contracted HIV. The exact point in time can only be established in the first eight weeks after infection – during the so called acute phase. If the HIV test is taken later, it remains unclear if the infection took place three months or ten years ago. But this is about to change as researchers supported by the Swiss National Science Foundation (SNSF) have discovered a simple method to determine the approximate time of infection.

Relevant to understanding the spread of the illness
According to Huldrych Günthard from the university hospital in Zurich, information regarding the time of infection is beneficial in many ways. It allows doctors to establish how quick the illness is progressing and to determine the start of treatment accordingly. It will also inform epidemiological studies interested in how the disease is spreading.

In collaboration with colleagues from the ETH Zurich, researchers of the Swiss HIV Cohort Study analysed data that is obtained in routine resistance tests. These tests examine the genetics of the virus to establish its resistance to drugs. If a patient carries a variety of HIV strains, the test reveals ambiguous results with regard to certain points in the sequences of the virus’ genetic code.

By-product of resistance testing
"For a long time, the ambiguous results of the viral sequencing were considered a by-product of the test," says Günthard. "We wondered if they were an indicator of the variety of viruses in the blood." Viral variety is a result of reproduction and evolution in the body, it increases with time and the ambiguity could therefore be an indicator for the time that has passed since infection. Günthard and his team tested this assumption by comparing the drug resistance data with an existing rudimentary method to calculate the time of infection. Additionally there are patients who know the exact time of HIV infection: e.g. patients who took the test during the acute phase or patients who took tests before and after the infection.

The study, that has now been published in the journal "Clinical Infectious Diseases", was able to show that the proportion of ambiguous sequences is indeed increasing regularly during the first eight years after infection, afterwards the increase slows down. At the moment the new method is still too imprecise to establish the exact time of infection but the researchers were able to define a threshold level that indicates with 99 percent certainty if an infection happened more than a year ago.

(*) Roger D. Kouyos, Viktor von Wyl, Sabine Yerly, Jürg Böni, Philip Rieder, Beda Joos, Patrick Taffé , Cyril Shah, Philippe Bürgisser, Thomas Klimkait, Rainer Weber, Bernard Hirschel, Matthias Cavassini, Andri Rauch, Manuel Battegay, Pietro L. Vernazza, Enos Bernasconi, Bruno Ledergerber, Sebastian Bonhoeffer, Huldrych F. Günthard and the Swiss HIV Cohort Study (2011). Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection. Clinical Infectious Diseases online. doi: 10.1093/cid/ciq164 (als PDF beim SNF erhältlich; E-Mail: pri@snf.ch)

Swiss HIV Cohort Study
Established in 1988, the study aims to expand our understanding of the illness and to improve patient care. All Swiss hospitals specialising in HIV (Basel, Bern, Geneva, Lausanne, Lugano, St. Gallen and Zurich) have gathered and analysed data regarding the course of the illness from over 16,000 HIV positive persons. Currently more than 7500 people participate in the Swiss HIV Cohort Study, almost a third are women.

www.shcs.ch

Contact:
Prof. Dr. med. Huldrych Günthard
Klinik für Infektionskrankheiten und Spitalhygiene
Universitätsspital Zürich
Rämistrasse 100
8091 Zürich
Tel.: +41 (0)44 255 34 50
E-Mail: huldrych.guenthard@usz.ch

| idw
Further information:
http://www.snf.ch

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

Construction of practical quantum computers radically simplified

05.12.2016 | Information Technology

NASA's AIM observes early noctilucent ice clouds over Antarctica

05.12.2016 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>